arrow
P

Paul W. Burridge

northwestern university
H指数:45
被引数:9,804

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Quality standards for preclinical research in cardio-oncology: A scientific statement of the ESC Council of Cardio-Oncology and the ESC Council on Basic Cardiovascular Science

心肿瘤学领域预临床研究的质量标准:欧洲心脏病学会心肿瘤学理事会和欧洲心脏病学会基础心血管科学理事会的科学声明

2026-09-070
OAAI
Functional in vitro assessment of the HER2 Ile655Val variant on trastuzumab-induced cardiotoxicity in human cardiomyocytes

HER2 Ile655Val变异体对人源心肌细胞曲妥珠单抗诱导的心脏毒性的体外功能评估

2025-12-190
PRE
Predicting the 10-year risk of cardiomyopathy in long-term survivors of childhood cancer☆

预测儿童癌症长期幸存者10年内发生心肌病的风险☆

2025-06-040
PRE
Serum Proteins Predict Treatment- Related Cardiomyopathy Among Survivors of Childhood Cancer

血清蛋白预测儿童癌症幸存者中与治疗相关的 cardiomyopathy

2025-01-010
OAAI
Susceptibility to innate immune activation in genetically mediated myocarditis
2024-05-161
OAAI
Gene-Level Analysis of Anthracycline-Induced Cardiomyopathy in Cancer Survivors A Report From COG-ALTE03N1, BMTSS, and CCSS

癌症幸存者中蒽环类药物诱导的心肌病的基因水平分析来自COG-ALTE03N1,BMTSS和CCSS的报告

2023-12-012
OA
Priorities in Cardio-Oncology Basic and Translational Science GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review
2023-12-0114
OA
Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report
2023-10-032
OAAI
Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy
2023-08-046
OAAI